SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-079878
Filing Date
2024-07-15
Accepted
2024-07-15 16:34:09
Documents
14
Period of Report
2024-08-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2419174d1_def14a.htm DEF 14A 718682
2 GRAPHIC tm2419174d1_def14aimg001.jpg GRAPHIC 14974
3 GRAPHIC tm2419174d1_def14aimg002.jpg GRAPHIC 11037
4 GRAPHIC tm2419174d1_def14aimg003.jpg GRAPHIC 13806
5 GRAPHIC tm2419174d1_def14aimg004.jpg GRAPHIC 15881
6 GRAPHIC tm2419174d1_def14aimg012.jpg GRAPHIC 207801
7 GRAPHIC tm2419174d1_def14aimg013.jpg GRAPHIC 126539
8 GRAPHIC tm2419174d1_def14amg005.jpg GRAPHIC 6082
9 GRAPHIC tm2419174d1_def14amg006.jpg GRAPHIC 21691
10 GRAPHIC tm2419174d1_def14amg007.jpg GRAPHIC 6407
11 GRAPHIC tm2419174d1_def14amg008.jpg GRAPHIC 7265
12 GRAPHIC tm2419174d1_def14amg009.jpg GRAPHIC 9271
13 GRAPHIC tm2419174d1_def14amg010.jpg GRAPHIC 7378
14 GRAPHIC tm2419174d1_def14amg011.jpg GRAPHIC 10310
  Complete submission text file 0001104659-24-079878.txt   1352923
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38899 | Film No.: 241117667
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)